Prevail Holdings, Inc

Prevail Holdings, Inc. selected for “Top 50 Healthcare Companies in the USA” by IFAH

Lafayette, La, May 8, 2019 PULSARIO Remote Heart Management System (RHMS) is once again recognized for industry leading management of cardiovascular diseases in the outpatient setting. The Pulsario’s proven system of optimizing health and quality of life of patients suffering from cardiovascular diseases while markedly reducing unnecessary hospital admissions, re-admissions and cost continues to impress users of the system and observers of the cardiovascular healthcare space alike. Pulsario is utilized by clinic-based physicians and nurse practitioners, nursing homes, assisted living facilities and home health agencies to deploy a novel innovative strategy of disease management via computer assisted monitoring and treatment. Patients utilize the system for education, assistance with lifestyle changes, medication compliance and to stay completely connected to their providers.

On the heels of being recognized as a European Healthcare SUPERTRENDS company for 2019, the IFAH has selected PULSARIO RHMS for “Top 50 Healthcare Companies in the USA.” The honor of this distinction was presented to Pulsario after an analysis of over 2000 leading-edge healthcare companies by the International Forum on Advancements in Healthcare (IFAH). The award will be presented to Pulsario at the IFAH US conference in June of 2019 in Las Vegas, Nevada.

“We continue to strive for exceptional medical care delivery via the unrivaled innovation of the Pulsario system. We are proud of the continued efforts by the entire team at Prevail Holdings, Inc., (the parent company of Pulsario RHMS and Prevail Heart Clinics of America) and are pleased with the response of our US expansion and adoption of the system into our partnering institutions. The ease of use, low cost of entry and econ have paved the way for rapid adoption and growth stability,” said Dr Kevin Courville, Founder and CEO.

About Pulsario Remote Heart Management System

With PULSARIO, we’ve developed a tool that can effectively lower the burden of management of cardiovascular disease by using computer-assisted medication titration, individualized patient monitoring and alerts, capitalizing on new revenue sources and lowering hospitalization and readmission rates and penalties.

Developed by Dr. Kevin A. Courville, a Cardiologist board-certified in Advanced Heart Failure and Transplantation, Interventional Cardiology and Cardiovascular Diseases, PULSARIO is a disruptive type of technology revolutionizing the outpatient management of heart failure and chronic cardiovascular disease. Our turn-key approach and multi-venue opportunity addresses the massive and growing problem of outpatient heart failure and chronic cardiovascular disease management – while improving the quality of life for patients and diminishing the physical and economic burden to providers, hospitals, hospital systems, and healthcare networks.

For more info:

Prevail Holdings, Inc.

(337) 456-3506